Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the cell based assays market size evolved in recent years?

The market size for cell-based assays has seen significant growth in recent years. It’s projected to increase from $27.07 billion in 2024 to $29.49 billion in 2025, yielding a compound annual growth rate (CAGR) of 8.9%. The growth observed in the historic period is due to the advent of HTS techniques, automated integration, use of biomarker detection, implementation of microfluidics, and the application of gene editing tools.

What are the predictions for the cell based assays market size in the coming years?

The size of the superfoods market is anticipated to experience robust growth in the upcoming years, with an estimated value of $263.78 billion in 2029 and a Compound Annual Growth Rate (CAGR) of 8.8%. Factors contributing to this predicted growth include intensifying health consciousness, varied dietary choices, the rise of e-commerce, innovations in product recipes, and the incorporation of global culinary. Key trends for the forecast period involve novelty in superfood snack types and diversity, the use of superfoods in cosmetic and skincare products, the introduction of superfood blends and powders, a focus on the ethical and sustainable procurement of superfood ingredients, and partnership ventures for studying the health advantages of superfoods.

Get your cell based assays market report here!

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

What key factors are fueling the growth of the cell based assays market?

The advancement and growing prevalence of research involving cell-based arrays have intensified the need for more accurate cellular models for drug discovery, as a countermeasure against late-stage drug failures. Pharmaceutical companies are motivated to enhance the innovation in cell-based assays in order to market drugs more effectively and avoid the costly mistakes often experienced in the final stages. A failure during Phase III of Investigational New Drug (IND) clinical trials could result in a loss of several hundred million dollars for the company involved. A study by Sigma suggests that the resulting return on investment for pharmaceutical companies could plummet to a meager 5% considering the present rate of late-stage failures — a substantial financial setback that most companies will find intolerable. However, thanks to key improvements to high-content systems and the data analysis gained through cell-based assays, researchers can obtain more comprehensive information regarding the cellular response. This contributes to more calculated decision-making processes throughout drug discovery, further propelling the growth of the cell-based array market.

How is the global cell based assays market divided into key segments?

The cell based assays market covered in this report is segmented –

1) By Product And Service: Consumables, Instruments, Services, Software

2) By Technology: Automated Handling, Flow Cytometry, Label-Free Detection, High-Throughput Screening, Other Technologies

3) By Application: Drug Discovery, Basic Research, Adme Studies, Predictive Toxicology, Other Applications

4) By End User: Pharmaceutical And Biotechnology Companies, Academic And Government Research Institutes, Contract Research Organizations (CRO), Other End Users

Subsegments:

1) By Consumables: Cell Culture Media, Reagents And Kits, Cell Lines, Microplates

2) By Instruments: Microplate Readers, Flow Cytometers, Cell Imaging Systems, Automated Cell Culture Systems

3) By Services: Custom Assay Development, Contract Research Services, Training And Consulting Services

4) By Software: Data Analysis Software, Lab Management Software, Simulation And Modeling Software

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2546&type=smp

Who are the key firms paving the way for growth in the cell based assays market?

Major companies operating in the cell based assays market include F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Corning Incorporated, Lonza Group Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., Miltenyi Biotec GmbH, Abcam plc, BioVision Inc., Promega Corporation, Cell Signaling Technology Inc., BioTek Instruments Inc., Enzo Life Sciences Inc., BioAgilytix Labs LLC, Cisbio International LLC, ProQinase GmbH, QGel SA, Biotium Inc., Selexis SA, Aurelia Bioscience Ltd., Creative Bioarray, Cell Biolabs Inc., Essen BioScience Ltd., Eurofins Scientific SE, DiscoveRx Corporation

Which trends are expected to transform the cell based assays market?

Scientists are beginning to shift towards preemptive toxicity tests in the early stages of drug development to avoid costly failures in later stages. There is a growing trend to enhance the capacity of predictive cell toxicity tests for higher compound screening in initial phases, mitigating the financial impact of unsuccessful attempts. One such company, Creative Bioarray, offers a variety of in vitro toxicity services to preempt potential drug-induced toxicities, saving both time and money by minimizing potential failures in earlier phases. These advancements are expected to simplify clinical testing and lower operational costs.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2546

What regions are contributing significantly to the growth of the cell based assays market?

North America was the largest region in the cell-based assays market in 2024. Western Europe was the second largest region in the global cell-based assays market share. The regions covered in the cell based assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cell Culture Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

Cellular Immunotherapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

Cell Therapy Technologies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: